Awards

Awards

iCLASS wins Best Product Launch at DOT 2024!
We’re honored to be recognized among this year’s top innovators. Thank you to everyone who joined us in Boston.

more news & insights

Dalriada Drug Discovery Announces Public Launch of iCLASS, a Live-Cell Chemoproteomics Platform for Early-Stage Small Molecule Discovery

April 16, 2026

Toronto, Canada — April 2026 — Dalriada Drug Discovery today announced the public launch of iCLASS™, a live-cell chemoproteomics platform and databank designed to support target discovery

Dalriada Drug Discovery and Topos Bio Announce Collaboration to Advance Drug Discovery for Intrinsically Disordered Proteins

March 17, 2026

Toronto, ON and San Francisco, CA — March 17, 2026 — Dalriada Drug Discovery (“Dalriada”), a partnered discovery organization supporting small-molecule programs from hit identification

Press Release

July 16, 2025

Dalriada Announces Strategic Collaboration on iCLASS Platform with a Public Computational Company Toronto, ON – July 16, 2025 – Dalriada announces a strategic collaboration with an

more news & insights

Dalriada Drug Discovery Announces Public Launch of iCLASS, a Live-Cell Chemoproteomics Platform for Early-Stage Small Molecule Discovery

Dalriada Drug Discovery and Topos Bio Announce Collaboration to Advance Drug Discovery for Intrinsically Disordered Proteins

Press Release

iCLASS

contact info

quick Links

newsletter

iCLASS

contact info

quick Links

newsletter

Be the first to find out about our new breakthrough

Subscribe to our newsletter!